These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8684714)

  • 21. Neurotensin in the nucleus accumbens reverses dopamine supersensitivity evoked by antipsychotic treatment.
    Servonnet A; Minogianis EA; Bouchard C; Bédard AM; Lévesque D; Rompré PP; Samaha AN
    Neuropharmacology; 2017 Sep; 123():10-21. PubMed ID: 28522313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurotensin receptor antagonist SR 142948A alters Fos expression and extrapyramidal side effect profile of typical and atypical antipsychotic drugs.
    Binder EB; Kinkead B; Owens MJ; Nemeroff CB
    Neuropsychopharmacology; 2004 Dec; 29(12):2200-7. PubMed ID: 15328528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction patterns of transcription factors of the nur family (nurr1, nur77, and nor-1) by typical and atypical antipsychotics in the mouse brain: implication for their mechanism of action.
    Maheux J; Ethier I; Rouillard C; Lévesque D
    J Pharmacol Exp Ther; 2005 Apr; 313(1):460-73. PubMed ID: 15615863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of the stereoisomers of butaclamol on neurotensin content in discrete regions of the rat brain.
    Bissette G; Dauer WT; Kilts CD; O'Connor L; Nemeroff CB
    Neuropsychopharmacology; 1988 Dec; 1(4):329-35. PubMed ID: 2472151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurotensin, antipsychotic drugs, and schizophrenia. Basic and clinical studies.
    Nemeroff CB; Levant B; Myers B; Bissette G
    Ann N Y Acad Sci; 1992; 668():146-56. PubMed ID: 1361110
    [No Abstract]   [Full Text] [Related]  

  • 26. Novel treatments of schizophrenia: targeting the neurotensin system.
    Kinkead B; Nemeroff CB
    CNS Neurol Disord Drug Targets; 2006 Apr; 5(2):205-18. PubMed ID: 16611093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurotensin, N-acetyl-aspartylglutamate and beta-endorphin modulate [3H]dopamine release from guinea pig nucleus accumbens, prefrontal cortex and caudate-putamen.
    Weatherspoon JK; Frank AR; Werling LL
    Neuropeptides; 1996 Oct; 30(5):497-505. PubMed ID: 8923514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of anticholinergic drugs on regional brain neurotensin concentrations.
    Levant B; Bissette G; Nemeroff CB
    Eur J Pharmacol; 1989 Jun; 165(2-3):327-30. PubMed ID: 2776835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurotensin levels in specific brain regions and hypnotic sensitivity to ethanol and pentobarbital as a function of time after haloperidol administration in selectively bred rat lines.
    Erwin VG; Radcliffe R; Deitrich RA
    J Pharmacol Exp Ther; 2001 Nov; 299(2):698-704. PubMed ID: 11602683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of acute antipsychotic drug administration on the neurotensin system of the developing rat brain.
    Kinkead B; Owens MJ; Nemeroff CB
    Brain Res Dev Brain Res; 2000 Nov; 124(1-2):1-10. PubMed ID: 11113506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BMY 14802, a potential antipsychotic drug, increases expression of proneurotensin mRNA in the rat striatum.
    Levant B; Merchant KM; Dorsa DM; Nemeroff CB
    Brain Res Mol Brain Res; 1992 Feb; 12(4):279-84. PubMed ID: 1349718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The sigma receptor ligand SR 31742A increases neurotensin in the nucleus accumbens but not in the caudate-putamen of the rat.
    Labie C; Keane PE; Soubrié P; Le Fur G
    Eur J Pharmacol; 1993 Feb; 231(3):465-7. PubMed ID: 8095466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term effects of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor subtypes.
    Moran-Gates T; Massari C; Graulich A; Liégeois JF; Tarazi FI
    J Neurosci Res; 2006 Aug; 84(3):675-82. PubMed ID: 16810690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CI-943, a potential antipsychotic agent. I. Preclinical behavioral effects.
    Heffner TG; Downs DA; Meltzer LT; Wiley JN; Williams AE
    J Pharmacol Exp Ther; 1989 Oct; 251(1):105-12. PubMed ID: 2571712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurotensin gene expression and behavioral responses following administration of psychostimulants and antipsychotic drugs in dopamine D(3) receptor deficient mice.
    Betancur C; Lépée-Lorgeoux I; Cazillis M; Accili D; Fuchs S; Rostène W
    Neuropsychopharmacology; 2001 Feb; 24(2):170-82. PubMed ID: 11120399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute administration of neuroleptics decreases neurotensin metabolism on intact, regional rat brain slices.
    Konkoy CS; Waters SM; Davis TP
    J Pharmacol Exp Ther; 1994 May; 269(2):555-63. PubMed ID: 7910209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atypical antipsychotics: mechanism of action.
    Seeman P
    Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risperidone does not elevate neurotensin mRNA in rat nucleus accumbens and caudate-putamen.
    Mijnster MJ; Docter GJ; Voorn P
    Neuroreport; 1995 Nov; 6(16):2209-12. PubMed ID: 8595204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential responses by neurotensin systems in extrapyramidal and limbic structures to ibogaine and cocaine.
    Alburges ME; Hanson GR
    Brain Res; 1999 Feb; 818(1):96-104. PubMed ID: 9914442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological differentiation of classical and novel antipsychotics.
    Arnt J
    Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S7-14. PubMed ID: 9690964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.